$130.00 Original price was: $130.00.$6.00Current price is: $6.00.
Edited by renowned experts in the field, Atta-ur-Rahman and Muhammad Iqbal Choudhary, this comprehensive compilation delves into the latest breakthroughs in Alzheimer’s disease (AD) research, providing invaluable insights for scientists, researchers, and healthcare professionals.
The book begins with an exhaustive overview of AD pharmacotherapy, highlighting the effectiveness of existing blockbuster drugs and the need for innovative approaches to tackle this complex neurodegenerative disorder.
The potential of both natural and synthetic small molecules is explored, shedding light on their role in AD treatment and prevention. The inhibition of cholinesterases, a crucial enzyme implicated in the onset and progression of AD, is also examined in depth.
The role of beta-site APP clearing enzyme-1 (BACE-1) in the production of β-amyloid proteins, a hallmark of AD, is discussed at length. This section provides a thorough analysis of BACE-1 as a promising target for AD drug development, offering a glimmer of hope for the millions affected by this debilitating disease.
Featuring 16 comprehensive reviews written by leading global researchers, this compilation is an indispensable resource for anyone seeking to stay abreast of the latest developments in AD research and neurodegenerative disease drug development.
Key Highlights:
Product Details:
Pages: 784
Publisher: Elsevier
Publication Date: June 16, 2015
Language: English
ISBN-10: 0128039590
ISBN-13: 978-0128039595
Author |
---|
Fermentum tempor cubilia risus tellus massa dis consectetur dolor.
WhatsApp Chat Oniline